Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma

Giovanina M. Ellis, Madhumita Mahalanabis, Ingrid A. Beck, Gregory Pepper, Amy Wright, Shannon Hamilton, Sarah Holte, Willscott (Scott) Naugler, Diane M. Pawluk, Chung Chen Li, Lisa M. Frenkel

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Drug-resistant mutants of human immunodeficiency virus type 1 (HIV-1) recede below the limit of detection of most assays applied to plasma when selective pressure is altered due to changes in antiretroviral treatment (ART). Viral variants with different mutations are selected by the new ART when replication is not suppressed or wild-type variants with greater replication fitness outgrow mutants following the cessation of ART. Mutants selected by past ART appear to persist in reservoirs even when not detected in the plasma, and when conferring cross-resistance they can compromise the efficacy of novel ART. Oligonucleotide ligation assay (OLA) of virus in plasma and peripheral blood mononuclear cells (PBMC) was compared to consensus sequence dideoxynucleotide chain terminator sequencing for detection of 91 drug resistance mutations that had receded below the limit of detection by sequencing of plasma. OLA of plasma virus detected 27.5% (95% confidence interval [CI], 19 to 39%) of mutant genotypes; consensus sequencing of the PBMC amplicon from the same specimen detected 23.1% (95% CI, 14 to 34%); and OLA of PBMC detected 53.8% (95% CI, 44 to 64%). These data suggest that concentrations of drug-resistant mutants were greater in PBMC than in plasma after changes in ART and indicate that the OLA was more sensitive than consensus sequencing in detecting low levels of select drug-resistant mutants.

Original languageEnglish (US)
Pages (from-to)3670-3674
Number of pages5
JournalJournal of Clinical Microbiology
Volume42
Issue number8
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Oligonucleotides
Ligation
HIV-1
Blood Cells
Pharmaceutical Preparations
Confidence Intervals
Limit of Detection
Dideoxynucleotides
Viruses
Therapeutics
Mutation
Withholding Treatment
Consensus Sequence
Drug Resistance
Genotype

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. / Ellis, Giovanina M.; Mahalanabis, Madhumita; Beck, Ingrid A.; Pepper, Gregory; Wright, Amy; Hamilton, Shannon; Holte, Sarah; Naugler, Willscott (Scott); Pawluk, Diane M.; Li, Chung Chen; Frenkel, Lisa M.

In: Journal of Clinical Microbiology, Vol. 42, No. 8, 08.2004, p. 3670-3674.

Research output: Contribution to journalArticle

Ellis, Giovanina M. ; Mahalanabis, Madhumita ; Beck, Ingrid A. ; Pepper, Gregory ; Wright, Amy ; Hamilton, Shannon ; Holte, Sarah ; Naugler, Willscott (Scott) ; Pawluk, Diane M. ; Li, Chung Chen ; Frenkel, Lisa M. / Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. In: Journal of Clinical Microbiology. 2004 ; Vol. 42, No. 8. pp. 3670-3674.
@article{b12672bcafc64e4a8cddaa480c2255bc,
title = "Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma",
abstract = "Drug-resistant mutants of human immunodeficiency virus type 1 (HIV-1) recede below the limit of detection of most assays applied to plasma when selective pressure is altered due to changes in antiretroviral treatment (ART). Viral variants with different mutations are selected by the new ART when replication is not suppressed or wild-type variants with greater replication fitness outgrow mutants following the cessation of ART. Mutants selected by past ART appear to persist in reservoirs even when not detected in the plasma, and when conferring cross-resistance they can compromise the efficacy of novel ART. Oligonucleotide ligation assay (OLA) of virus in plasma and peripheral blood mononuclear cells (PBMC) was compared to consensus sequence dideoxynucleotide chain terminator sequencing for detection of 91 drug resistance mutations that had receded below the limit of detection by sequencing of plasma. OLA of plasma virus detected 27.5{\%} (95{\%} confidence interval [CI], 19 to 39{\%}) of mutant genotypes; consensus sequencing of the PBMC amplicon from the same specimen detected 23.1{\%} (95{\%} CI, 14 to 34{\%}); and OLA of PBMC detected 53.8{\%} (95{\%} CI, 44 to 64{\%}). These data suggest that concentrations of drug-resistant mutants were greater in PBMC than in plasma after changes in ART and indicate that the OLA was more sensitive than consensus sequencing in detecting low levels of select drug-resistant mutants.",
author = "Ellis, {Giovanina M.} and Madhumita Mahalanabis and Beck, {Ingrid A.} and Gregory Pepper and Amy Wright and Shannon Hamilton and Sarah Holte and Naugler, {Willscott (Scott)} and Pawluk, {Diane M.} and Li, {Chung Chen} and Frenkel, {Lisa M.}",
year = "2004",
month = "8",
doi = "10.1128/JCM.42.8.3670-3674.2004",
language = "English (US)",
volume = "42",
pages = "3670--3674",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma

AU - Ellis, Giovanina M.

AU - Mahalanabis, Madhumita

AU - Beck, Ingrid A.

AU - Pepper, Gregory

AU - Wright, Amy

AU - Hamilton, Shannon

AU - Holte, Sarah

AU - Naugler, Willscott (Scott)

AU - Pawluk, Diane M.

AU - Li, Chung Chen

AU - Frenkel, Lisa M.

PY - 2004/8

Y1 - 2004/8

N2 - Drug-resistant mutants of human immunodeficiency virus type 1 (HIV-1) recede below the limit of detection of most assays applied to plasma when selective pressure is altered due to changes in antiretroviral treatment (ART). Viral variants with different mutations are selected by the new ART when replication is not suppressed or wild-type variants with greater replication fitness outgrow mutants following the cessation of ART. Mutants selected by past ART appear to persist in reservoirs even when not detected in the plasma, and when conferring cross-resistance they can compromise the efficacy of novel ART. Oligonucleotide ligation assay (OLA) of virus in plasma and peripheral blood mononuclear cells (PBMC) was compared to consensus sequence dideoxynucleotide chain terminator sequencing for detection of 91 drug resistance mutations that had receded below the limit of detection by sequencing of plasma. OLA of plasma virus detected 27.5% (95% confidence interval [CI], 19 to 39%) of mutant genotypes; consensus sequencing of the PBMC amplicon from the same specimen detected 23.1% (95% CI, 14 to 34%); and OLA of PBMC detected 53.8% (95% CI, 44 to 64%). These data suggest that concentrations of drug-resistant mutants were greater in PBMC than in plasma after changes in ART and indicate that the OLA was more sensitive than consensus sequencing in detecting low levels of select drug-resistant mutants.

AB - Drug-resistant mutants of human immunodeficiency virus type 1 (HIV-1) recede below the limit of detection of most assays applied to plasma when selective pressure is altered due to changes in antiretroviral treatment (ART). Viral variants with different mutations are selected by the new ART when replication is not suppressed or wild-type variants with greater replication fitness outgrow mutants following the cessation of ART. Mutants selected by past ART appear to persist in reservoirs even when not detected in the plasma, and when conferring cross-resistance they can compromise the efficacy of novel ART. Oligonucleotide ligation assay (OLA) of virus in plasma and peripheral blood mononuclear cells (PBMC) was compared to consensus sequence dideoxynucleotide chain terminator sequencing for detection of 91 drug resistance mutations that had receded below the limit of detection by sequencing of plasma. OLA of plasma virus detected 27.5% (95% confidence interval [CI], 19 to 39%) of mutant genotypes; consensus sequencing of the PBMC amplicon from the same specimen detected 23.1% (95% CI, 14 to 34%); and OLA of PBMC detected 53.8% (95% CI, 44 to 64%). These data suggest that concentrations of drug-resistant mutants were greater in PBMC than in plasma after changes in ART and indicate that the OLA was more sensitive than consensus sequencing in detecting low levels of select drug-resistant mutants.

UR - http://www.scopus.com/inward/record.url?scp=3843061329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843061329&partnerID=8YFLogxK

U2 - 10.1128/JCM.42.8.3670-3674.2004

DO - 10.1128/JCM.42.8.3670-3674.2004

M3 - Article

C2 - 15297515

AN - SCOPUS:3843061329

VL - 42

SP - 3670

EP - 3674

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 8

ER -